Skip to main content
Premium Trial:

Request an Annual Quote

Therapy Lottery

The plan to hold a lottery to give away 100 free doses of the gene therapy Zolgensma has been met with consternation, the Guardian reports.

The US Food and Drug Administration approved Novartis' Zolgensma in May for children with spinal muscular atrophy who are under the age of two. The disease causes paralysis, breathing difficulties, and death, and Zolgensma is a one-time treatment that delivers a working copy of the SMN gene to prevent its progression. But Zolgensma is also expensive, with a list price of $2.1 million.

According to the Guardian, parents of children with SMA are put off by both the drug's high cost, but also the lottery. "SMA is still the biggest killer of children under two," Lucy Frost, whose son has the disease and who is a trustee of TreatSMA tells it. "Imagine parents putting a child in a draw every two weeks to see if their life can be saved. It will have a huge emotional impact." 

A Novartis spokesperson says the drug is fairly priced, as it is a one-time treatment, and that it costs less than the standard of care treatment, the Guardian adds, noting that AveXis, which developed the drug and was bought by Novartis, says it is working to "design sustainable and ethical solutions" to address access concerns.

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar length distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.